When introduced into the endocannabinoid system, CBD causes an increased release of 2-AG, one of the body’s endogenous cannabinoids. Like CBD, 2-AG stimulates both CB1 and CB2 receptors, which enhances the overall effect on the body. Studies published by the National Institutes of Health have shown that CBD also inhibits the activity of fatty acid amide hydroxylase, or FAAH. This slows the deterioration of anandamide, another important endogenous cannabinoid found naturally within the body.
Implications in Medicine
CBD’s impact on the ECS, as well as its other effects on the human body, indicate that this substance may be useful in treating a variety of medical conditions. Cannabidiol’s neuroprotectant qualities help to protect the brain from injury. WADA, or the World Anti-Doping Agency, recently removed CBD from the banned substance list because of its safety and efficacy in helping the body to recover and repair itself.
Medical research involving the possible uses of CBD is ongoing, the list of conditions CBD could potentially treat continues to grow. Currently, the list includes the conditions listed above, as well as mood disorders, diabetes, heart disease, glaucoma, asthma, stroke and many more.
What is the role of the ECS?
How does CBD benefit you?